Clinical Research Directory
Browse clinical research sites, groups, and studies.
Observational Study to Assess the Effectiveness of VLA1553 Vaccine in Preventing Chikungunya During a Pilot Vaccination Strategy in Brazil
Sponsor: Valneva Austria GmbH
Summary
This is an observational, non-interventional, test-negative case-control (TNCC) study to estimate the vaccine effectiveness of VLA1553 against Chikungunya virus in a real-world setting.
Official title: A Test-Negative Case-control Study to Evaluate the Effectiveness of VLA1553 Against Chikungunya Virus Disease During a Pilot Vaccination Strategy in Brazil
Key Details
Gender
All
Age Range
18 Years - 59 Years
Study Type
OBSERVATIONAL
Enrollment
1200
Start Date
2026-02-02
Completion Date
2027-12-31
Last Updated
2026-07-17
Healthy Volunteers
Yes
Conditions
Interventions
Live-attenuated CHIKV vaccine VLA1553
Non-interventional study: VLA1553 is used in the pilot vaccination strategy which is linked to this observational study.
Locations (3)
Universidade Federal de Minas Gerais, CT Terapias Avançadas e Inovadoras
Belo Horizonte, Minas Gerais, Brazil
Centro de Pesquisas Clínicas Universidade Federal Sergipe, Hospital e Maternidade São João de Deus
Laranjeiras, Sergipe, Brazil
Fundação Faculdade Regional De Medicina De São José Do Rio Preto
São Pedro, São Paulo, Brazil